newsfilter
← Latest News
PR Newswire·

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives ...